Dissecting the effects of METTL3 on alternative splicing in prostate cancer

Lin Wang1,2, Ling Shi2, Yonghao Liang2

  • 1Metabolic Disease Research Center, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China.

Frontiers in Oncology
|September 7, 2023
PubMed

Insights

METTL3 regulates alternative splicing (AS) in prostate cancer (PCa) by affecting exon skipping and intron retention. METTL3-dependent AS events, influenced by N6-methyladenosine (m6A), highlight MKNK2 AS events as potential PCa biomarkers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • METTL3's role in cancer is known, but its function in prostate cancer (PCa) isoform switching via alternative splicing (AS) remains understudied.
  • Prostate cancer exhibits significant heterogeneity, with androgen-sensitive and resistant subtypes potentially displaying distinct molecular mechanisms.

Purpose of the Study:

  • To investigate the role of METTL3 in regulating alternative splicing (AS) in prostate cancer (PCa).
  • To explore the impact of METTL3 depletion on AS events in different PCa subtypes.
  • To identify potential prognostic biomarkers associated with METTL3-regulated AS in PCa.

Main Methods:

  • Utilized standard RNA-sequencing and long-read direct RNA-sequencing (Oxford Nanopore).
  • Analyzed genome-wide METTL3-regulated alternative splicing events in two distinct PCa cell lines.
  • Investigated the dependence of METTL3-regulated AS on N6-methyladenosine (m6A) and splicing factors.

Main Results:

  • METTL3 depletion induced differential AS events (exon skipping, intron retention) in androgen-sensitive versus resistant PCa cell lines, indicating AS heterogeneity.
  • METTL3-regulated AS is dependent on m6A modification and specific splicing factors.
  • Identified cell type-specific AS signatures for genes like MKNK2, crucial for PCa tumorigenesis.
  • Validated the clinical relevance of MKNK2 AS events in PCa patients, suggesting an m6A-mediated regulatory mechanism involving SRSF1.

Conclusions:

  • METTL3 plays a significant role in regulating PCa-associated alternative splicing programs.
  • The findings expand the understanding of METTL3's function in tumorigenesis.
  • MKNK2 alternative splicing events represent a promising novel prognostic biomarker for prostate cancer.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.5K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.4K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
7.0K
What is Gene Expression?01:36

What is Gene Expression?

A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised  of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then...
8.6K